AtlantiCare Selects MEDai's Predictive Analytics Solutions

Health Engagement Program to use MEDai's Risk Navigator as Tool in Coordinating Care Delivery

ORLANDO, Florida, April 4, 2011 - AtlantiCare, the largest health system in southeastern New Jersey, will
allow its healthcare providers to better manage patient populations and track
clinical and financial objectives with quality-focused tools from
Elsevier/MEDai, a leading provider of predictive analytic solutions.

AtlantiCare's vision is to build healthy communities. It will use MEDai's
Risk Navigator solutions to provide analytics for its Health Engagement
program, which is positioned to prevent injury and illness, and manage health
risks, chronic illnesses and healthcare utilization. Additionally,
AtlantiCare is part of Premier, a collaborative to design and implement an
Accountable Care Organization (ACO) in New Jersey. ACOs are designed to keep
patients healthy and out of intensive care settings, while simultaneously
shifting reimbursements to be based on quality outcomes and efficiencies.

AtlantiCare will use MEDai's Risk Navigator solutions in conjunction with
its patient-centered medical home model to enhance cooperation and
communication between plan, provider and nurse case managers. Risk Navigator
provides the ability to integrate data from multiple sources and systems and
produce information that is needed to provide proactive patient care.

"The collaborative nature of ACOs is an extremely important step in the
evolution of our nation's healthcare systems," said Clayton Ramsey, COO,
MEDai. "MEDai's predictive analytics and healthcare expertise aid clients in
ensuring they have the necessary resources to make quality, efficient
patient-care decisions based on accurate information."

For more than a decade, MEDai's predictive modeling suite has accurately
forecasted prospective high-risk patients to improve patients' health and
quality of care while controlling cost. Risk Navigator Clinical is built to
fit the clinical workflow by wrapping business intelligence around a
member-centric database providing evidence-based medicine guideline
compliance information and cost and utilization forecasts. Clients can also
leverage MEDai's motivation index to determine the level of member engagement
most appropriate based on the members' motivation to self manage their
conditions.

About MEDai

MEDai, Inc. is a subsidiary of Elsevier, a world-leading publisher of
more than 2,000 scientific, technical and medical information products and
services. MEDai offers award-winning solutions for the improvement of
healthcare delivery. Utilizing cutting-edge technology, payors and care
management organizations are able to predict patients at risk, identify cost
drivers for their high-risk population, forecast future health plan costs,
evaluate patient patterns over time and improve outcomes. For more
information on MEDai, visit www.medai.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com), SciVerse Scopus
(www.scopus.com), Reaxys (www.reaxys.com), MD Consult
(www.mdconsult.com) and Nursing Consult (www.nursingconsult.com
), which enhance the productivity of science and health professionals, and
the SciVal suite (www.scival.com) and MEDai's Pinpoint Review
(www.medai.com), which help research and health care institutions
deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact
    Tom Reller
    Vice President of Global Relations, Elsevier
    +1-212-462-1912
    T.Reller@Elsevier.com

Media Contact: Tom Reller, Vice President of Global Relations, Elsevier, +1-212-462-1912, T.Reller at Elsevier.com